Name | N,N,N',N'-tetrakis[(6-methyl-1H-benzimidazol-2-yl)methyl]ethane-1,2-diamine |
---|---|
Synonyms |
N,N,N',N'-Tetrakis[(6-methyl-1H-benzimidazol-2-yl)methyl]-1,2-ethanediamine
1,2-Ethanediamine, N,N,N,N-tetrakis[(6-methyl-1H-benzimidazol-2-yl)methyl]- NSC348884 |
Description | NSC348884 is a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis, inhibits cell proliferation at an IC50 of 1.7-4.0 μM in distinct cancer cell lines.Target: nucleophosminin vitro: NSC348884 is a putative nucleophosmin small molecular inhibitor that disrupts a defined hydrophobic pocket required for oligomerization. NSC348884 disrupts nucleophosmin oligomer formation by native polyacrylamide gel electrophoresis assay. NSC348884 upregulates p53. NSC348884 induces apoptosis.[1] |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 1001.7±65.0 °C at 760 mmHg |
Molecular Formula | C38H40N10 |
Molecular Weight | 636.791 |
Flash Point | 559.6±34.3 °C |
Exact Mass | 636.343750 |
PSA | 121.20000 |
LogP | 4.74 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.768 |
Storage condition | 2-8°C |